FDA批准一款肝脏治疗设备后,TriSalus股价大涨

路透中文
Sep 23
BUZZ-FDA批准一款肝脏治疗设备后,TriSalus股价大涨

最新动态

9月23日 - ** 癌症治疗公司 TriSalus(TLSI.O)股价上涨 7.5%,至 5.3 美元

** 该公司 (link) 旗下Trinav Advance设备获得FDA批准,进一步扩充了其面向肝脏靶向治疗的产品组合

** 该公司计划在未来几周内对该设备进行小范围上市

** 五家券商对该股评级为“买入”;目标价中位数为9美元——数据由LSEG汇编

** 计入当日波动,该股年初至今累计下跌29.4%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10